Reaction Biology
Drug Discovery · Biotechnology
Has an LEI
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 17, 2026Reaction Biology offers a comprehensive spectrum of drug discovery CRO services including fee-for-service preclinical drug testing and integrated drug discovery.
- Headquarters
- Malvern, United States
- Founded
- 2001
- Official records
- Wikidata Q106411726LEI 254900JE0M3W26KAP066
- Website
- reactionbiology.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 4 cities in 2 countries.
4Cities
2Countries
Loading the map
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Malvern United States | Headquarters | 0 | ||
| Freiburg im Breisgau Germany | Regional office | 0 | ||
| Heidelberg Germany | Regional office | 0 | ||
| Hershey United States | Regional office | 0 |
Source: office addresses in postings and company registers
Financials
3 public grants on record, $3.3M in total.
$3.3MPublic grants3 public grants
Money by yearUSD, rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Feb 1, 2017
Won a grant $1.6M · CORDIS
Apr 1, 2016
Won a grant $248k · CORDIS
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 82026
Blog
Why Kinase Selectivity Demands Multiple Assay Formats The human kinome comprises more than 500 kinases sharing a conserved ATP-binding pocket and high structural homology. This c…
Aug 12026
Blog
Participants: Haiching Ma, PhD (Founder & CSO, Reaction Biology), Jason Amsbaugh, MBA (CEO, Samba Scientific), Trent Carrier, PhD, MBA (CEO, Carolina Molecular) Overview Reaction…
Jul 272026
Blog
Headlines In This Issue Scientific Spotlight Our biochemical kinase platform, including HotSpot and ³³PanQinase, comprise the largest kinase library in the industry. Featured Res…
May 152026
Blog
Headlines In This Issue Scientific Spotlight: Immuno-Oncology Explore how tumor-associated macrophages influence therapeutic outcomes and why comprehensive preclinical models are…
Mar 262026
Blog
Over 100 kinase inhibitors have now been approved by the FDA, transforming the treatment of cancer and other diseases.¹ Yet despite this progress, a key question remains underexp…
Feb 192026
Blog
Immunological impact across diseases Far more therapeutic areas involve immune regulation than traditional disease boundaries have suggested, leading to practical implications fo…
Sources: the outlets named on each headline, each story once
